Ying Fu

Publication Activity (10 Years)

Years Active: 2021-2022
Publications (10 Years): 3

Top Topics

Candida Albicans

Angiotensin Converting Enzyme

Metastatic Renal Cell Carcinoma

Top Venues

Molecules (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Ying Fu, Rengui Saxu, Kadir Ahmad Ridwan, Jiaping Yao, Xiaoxuan Chen, Xueping Xu, Weida Zheng, Peng Yu, Yuou Teng
Losartan Alleviates the Side Effects and Maintains the Anticancer Activity of Axitinib. Molecules (Basel, Switzerland) 27 (9) (2022)
Ying Fu, Rengui Saxu, Kadir Ahmad Ridwan, Cai Zhao, Xiangshun Kong, Yao Rong, Weida Zheng, Peng Yu, Yuou Teng
Selenium substituted axitinib reduces axitinib side effects and maintains its anti-renal tumor activity. RSC advances 12 (34) (2022)
Ying Fu, Cai Zhao, Rengui Saxu, Chaoran Yao, Lianbo Zhao, Weida Zheng, Peng Yu, Yuou Teng
Anastatin Derivatives Alleviate Myocardial Ischemia-Reperfusion Injury via Antioxidative Properties. Molecules (Basel, Switzerland) 26 (16) (2021)